Stocktoria
FIREFLY NEUROSCIENCE, INC. AIFF
FIREFLY NEUROSCIENCE, INC. (AIFF) earns a Piotroski F-score of 4/9 (mixed financial health). It does not currently pay a dividend. FY2025 revenue was $1.1M at a -1741.0% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: 0.87 — elevated (above the −1.78 line — aggressive-accounting signals worth a closer look) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| AIFF | FIREFLY NEUROSCIENCE, INC. | 4/9 | — | — | — |
| WCT | Wellchange Holdings Co Ltd | 4/9 | 2.33 | — | — |
| ATHR | Aether Holdings, Inc. | 3/9 | — | — | — |
| SITS | SOUTHERN ITS INTERNATIONAL, INC. | 2/9 | — | — | — |
| MTC | MMTEC, INC. | 3/9 | -16.68 | — | — |
| SVMB | Jingbo Technology, Inc. | 5/9 | -16.66 | — | — |
| PXLW | PIXELWORKS, INC | 3/9 | — | — | -98.4% |
About FIREFLY NEUROSCIENCE, INC.
Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.
FAQ
Is AIFF financially healthy?
FIREFLY NEUROSCIENCE, INC.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).
Does AIFF pay a dividend?
No, FIREFLY NEUROSCIENCE, INC. does not currently pay a dividend.
How profitable is AIFF?
In FY2025, FIREFLY NEUROSCIENCE, INC. had a net margin of -1741.0% and a return on equity of -260.3%.
Is AIFF overvalued or undervalued?
FIREFLY NEUROSCIENCE, INC. trades at about 37.0× trailing earnings — below its 10-year norm (10-year range 390.0×–1750.0×, median 510.0×). Stocktoria reports the data, not buy/sell advice.
Is AIFF a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on FIREFLY NEUROSCIENCE, INC.: a Piotroski F-score of 4/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.